2026· International Journal of Medicine in Developing Countries· pp. 1· 0 citations
TL;DR
Remimazolam was more hemodynamically stable than propofol during TIVA and produced a comparable quality of recovery, which might help to rapidly restore consciousness.
Abstract
Remimazolam is an ultra-short-acting benzodiazepine that has been developed as a new option for total intravenous anesthesia (TIVA) and might have benefits in terms of hemodynamic stability and recovery profiles. The purpose of this systematic review was to compare the hemodynamic stability and recovery between remimazolam and propofol in adult TIVA patients. The PubMed/MEDLINE, Embase, CENTRAL, and Web of Science databases were searched using the PubMed/MEDLINE, Embase, CENTRAL, and Web of Science search engines, respectively, to find randomized controlled trials (RCTs) published in the past 5 years that compared remimazolam-based TIVA with propofol-based TIVA. Outcomes were hemodynamic parameters, recovery quality, and adverse events. Cochrane RoB 2 was used to evaluate risk of bias. Total 11 RCTs including a wide range of surgical populations were included. Remimazolam was consistently shown to be more hemodynamically stable, with significantly fewer incidences of hypotension (such as during induction (6.7% vs. 28.9%)) and lower vasopressor use. The quality of recovery (QoR-15) score was not inferior to those with propofol. Recovery profiles were variable: some studies suggested that extubation was slower with remimazolam, whereas others indicated that recovery was quicker with flumazenil. Incidence of PONV was similar, and pain at injection was significantly less with remimazolam. Remimazolam was more hemodynamically stable than propofol during TIVA and produced a comparable quality of recovery. Flumazenil might help to rapidly restore consciousness. Remimazolam can be used in patients who are at risk of developing hemodynamic instability.
BACKGROUND
Propofol is widely used for sedation in the intensive care unit (ICU), but its use may be limited by cardiovascular depression, hypertriglyceridemia, and propofol infusion syndrome. Remimazolam has emerged as a potential alternative to propofol, with rapid metabolism, predictable recovery, and flumazenil rev...
Shunichi Nakahara, A. Velarde Pineda, C. A. Romero Bonifaz et al.· Journal of critical care· 0 citations
OBJECTIVES
To compare remimazolam-based with propofol-based anesthesia for induction and maintenance in adult cardiac surgery.
DESIGN
Systematic review and meta-analysis of randomized controlled trials.
SETTING
Cardiovascular centers.
PARTICIPANTS
Adults undergoing cardiac surgery.
INTERVENTIONS
Remimazolam-bas...
Yun-Tai Yao, Shuo Huang, Hong-Bai Wang et al.· Journal of Cardiothoracic an...· 0 citations
BACKGROUND
Fiberoptic bronchoscopy requires effective sedation to ensure patient comfort while preserving gas exchange, hemodynamic stability, and predictable recovery. Remimazolam, a novel ultra-short-acting benzodiazepine, has emerged as a potential alternative to traditional sedatives. However, its safety and effica...
Soowon Lee, Hyo-Seok Na, B. Koo et al.· Journal of Bronchology & Int...· 0 citations
Current evidence supports individualized use rather than routine selection of remimazolam for delirium prevention, and the relatively consistent hemodynamic advantage of remimazolam should be regarded separately from neurocognitive benefit.
Dong-Yue Peng, Zhao-Yin Zhong, P. Zou et al.· Frontiers in Medicine· 0 citations
Background Postoperative delirium (POD) is a common complication in elderly surgical patients that can impede recovery. While remimazolam offers superior hemodynamic stability compared to propofol, its impact on POD incidence remains unclear. This randomized trial aimed to determine whether two induction doses of remim...
Hong-Na Fan, Xiao-Tong Chen, Lin-Lin Xu et al.· Frontiers in Medicine· 0 citations
Benzodiazepines have traditionally been associated with postoperative delirium (POD), but the effect of remimazolam on POD remains uncertain. This systematic review and meta-analysis evaluated the incidence of POD and perioperative safety outcomes associated with remimazolam in adults undergoing general anesthesia. We...
J. Bae, B. Lim, I. Lee· Anesthesia and Pain Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.